BLMN vs BZH

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a lack of Altman Z-Score raises concerns about bankruptcy risk assessment. Despite a high dividend yield of 7.83%, the unsustainable payout ratio of 186.49% and negative profitability metrics signal severe earnings pressure. Valuation multiples appear deceptively attractive due to low P/E and P/S ratios, but these are distorted by weak or negative margins and declining earnings. The technical trend is bearish, insider activity shows net selling, and long-term price performance remains deeply negative, reinforcing a high-risk profile.

BZH presents a contradictory profile: it is fundamentally cheap on an asset basis (P/B 0.53) but experiencing a severe operational collapse. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $22.45 sits significantly above the Graham Number ($16.55) and the growth-based intrinsic value ($2.03). With revenue declining by 22.5% YoY and a massive YoY EPS drop of 1150%, the company is currently in a sharp downward trajectory despite high liquidity.